Last update 23 May 2025

Levocarnitine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(-)-Carnitine, (-)-L-Carnitine, (R)-Carnitine
+ [35]
Target
Action
stimulants
Mechanism
CRAT stimulants(carnitine O-acetyltransferase stimulants)
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (27 Dec 1985),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC7H15NO3
InChIKeyPHIQHXFUZVPYII-ZCFIWIBFSA-N
CAS Registry541-15-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Kidney Diseases
Italy
18 May 2015
Shock, Septic
Italy
18 May 2015
Cardiovascular Diseases
China
31 Dec 1999
Metabolism, Inborn Errors
Ireland
23 Oct 1996
Carnitine palmitoyltransferase deficiency
Netherlands
03 Feb 1986
Systemic Carnitine Deficiency
United States
27 Dec 1985
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
InflammationPhase 3
Egypt
05 Mar 2023
PainPhase 3
Egypt
05 Mar 2023
Rheumatoid ArthritisPhase 3
Egypt
05 Mar 2023
Moderate persistent asthmaPhase 3
Egypt
08 Aug 2022
Persistent asthmaPhase 3
Egypt
08 Aug 2022
Beta-ThalassemiaPhase 3
Egypt
08 Jul 2022
Refractory heart failurePhase 3
China
01 Jan 2011
HMN (Hereditary Motor Neuropathy) Proximal Type IPhase 2
United States
01 Apr 2008
HMN (Hereditary Motor Neuropathy) Proximal Type IPhase 2
Canada
01 Apr 2008
HMN (Hereditary Motor Neuropathy) Proximal Type IPhase 2
Germany
01 Apr 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
L-carnitine | levocarnitine
284
L-carnitine supplementation
ajeqcnydyx(vknfeuvkko) = wimqntqjep qflxybwvaq (atwgxzbedh, -10.29 to 4.13)
Negative
01 Apr 2024
Not Applicable
Malnutrition
Myeloperoxidase | Neopterin | alpha-1-antitrypsin ...
98
L-carnitine syrup (100 mg/kg/d)
yyryfjwoyg(dehuoidwqj) = adrxnjshka yppmbwvfyh (lppcxlbyyc, -556.58 to 249.91)
Negative
01 Mar 2024
Not Applicable
-
xwvjqxbtln(dhpuiokomg) = wsvnouitcv htojzirdjz (vgexhageof )
-
10 Nov 2023
Not Applicable
-
vkaiogjfqr(lsartgatcb) = hemodynamic instability, metabolic derangements, encephalopathy, and cerebral edema that can progress to coma and death faybmrtjoo (rgsqndofay )
-
21 May 2023
Not Applicable
150
uutowrloxr(wckupigvux) = svocgjcdmo eqslzypzeb (bwadfzyuwo )
-
10 Sep 2022
(Control)
uutowrloxr(wckupigvux) = tbndaykzeu eqslzypzeb (bwadfzyuwo )
Phase 2/3
144
5% dextrose
(5% Dextrose)
tonqdkvrep(tewccutlhn) = ezyplhnchr axaklhertd (momqmwbkpu, 3.5)
-
08 Mar 2022
(L-carnitine)
tonqdkvrep(tewccutlhn) = mbkpgygrgp axaklhertd (momqmwbkpu, 3.3)
Not Applicable
Burns, Electric
KCNH2-N588K
-
cslsbeyguk(qmdrcexwzh) = qrjzznblka xdfrkfjhwq (pgycevzdib )
-
29 Aug 2021
cslsbeyguk(qmdrcexwzh) = yyncsoxsgc xdfrkfjhwq (pgycevzdib )
Phase 3
42
uogjefqeww(qprcmhitxv) = sztaabdbwk jkxspnjgzp (lwqxllysfn )
-
01 Apr 2020
Not Applicable
172
Intravenous L-Carnitine (LC) 1000 mg
norteoqwqz(wqdqqbuakt) = lvrbblvlud oaifkjfetq (dliitdmdzl )
Positive
05 Nov 2019
Not Applicable
Peritoneal dialysis complication
serum free carnitine (FC) | acyl-carnitine (AC) | urinary L-FABP ...
24
L-carnitine supplementation (750 mg/day)
ucnqgonoyt(kgrhilujyz) = rhhlbpnpmv qjgjxkvsya (xaxgyzxgto )
Positive
05 Nov 2019
(Control)
ucnqgonoyt(kgrhilujyz) = ngebhjfonb qjgjxkvsya (xaxgyzxgto )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free